“meningococcal vaccine”的搜索结果，显示 131-140 项，共有 4432 项

1. 百日咳 - 症状与病因- 妙佑医疗国际

   Tdap (Tetanus, Diphtheria, Pertussis) vaccine information statements. Centers for Disease Control and Prevention. https://www.cdc.gov/vaccines/hcp/vis/vis ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma. Rochester, Minn. The purpose of ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma. Rochester, Minn. The purpose of ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma. Rochester, Minn. The purpose of ...

5. 肾移植项目- 临床试验- 妙佑医疗国际

   Scottsdale/Phoenix, Ariz. Hypothesis: we hypothesize that the abundance and functions of Breg subsets in kidney transplant patients could be associated with ...

6. Mayo Clinic Physician Update - June 2023

   Page 1.

7. 妙佑医疗国际 - 有关强生腺病毒载体疫苗的解读

   医学博士Melanie Swift（COVID-19 疫苗分配和分发工作组）：腺病毒载体疫苗并非新鲜事物。腺病毒极为常见，它们几乎无处不在，经常导致普通感冒、红眼病等轻度感染。

8. 神经科- 临床试验- 妙佑医疗国际

   Jacksonville, Fla. The purpose of this study is to create a repository for cerebellar ataxia and nucleotide repeat diseases in order to fully investigate the ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma. Rochester, Minn. The purpose of ...

10. 传染病- 临床试验- 妙佑医疗国际

    T Cell Response to COVID19 Vaccinated Individuals. Rochester, Minn., Jacksonville, Fla. The first aim of this study is to verify that the TCR beta sequencing ...